Autologous Dendritic Cell HIV Vaccination(National Institute of Allergy & Infectious Diseases)(Autologous Dendritic Cell HIV Vaccination(National Institute of Allergy & Infectious Diseases))

概要

基本信息

药物类型

预防性疫苗、树突状细胞疫苗

别名-

靶点

HIV integrase

作用方式

调节剂

作用机制

HIV-1 integrase调节剂(HIV整合酶调节剂)

治疗领域-

在研适应症-

非在研适应症-

原研机构

National Institute of Allergy & Infectious Diseases

在研机构-

非在研机构-

权益机构-

最高研发阶段-

首次获批日期-

最高研发阶段(中国)-

特殊审评-

关联

1

项与 Autologous Dendritic Cell HIV Vaccination(National Institute of Allergy & Infectious Diseases) 相关的临床试验

NCT00056758

/ Completed临床1期IIT

Randomized Phase I Evaluation of Immunization With Highly Conserved HIV-1 Derived Peptides and Influenza Matrix Peptide in HIV-1-Infected Subjects on Highly Active Antiretroviral Therapy (HAART) Using Autologous Dendritic Cells Derived From Adherent Monocytic Precursors

This study will evaluate the safety of and immune responses to a dendritic cell vaccination for HIV-1 infection. The vaccine will be made from a patient's own cells combined with small fragments of HIV-1 (made synthetically in a laboratory). These cells will be administered back to the patient either into a vein (intravenously) or the skin (subcutaneously).

开始日期2003-02-01

申办/合作机构

National Institute of Allergy & Infectious Diseases

100 项与 Autologous Dendritic Cell HIV Vaccination(National Institute of Allergy & Infectious Diseases) 相关的临床结果

登录后查看更多信息

100 项与 Autologous Dendritic Cell HIV Vaccination(National Institute of Allergy & Infectious Diseases) 相关的转化医学

登录后查看更多信息

100 项与 Autologous Dendritic Cell HIV Vaccination(National Institute of Allergy & Infectious Diseases) 相关的专利（医药）

登录后查看更多信息

100 项与 Autologous Dendritic Cell HIV Vaccination(National Institute of Allergy & Infectious Diseases) 相关的药物交易

登录后查看更多信息